Publications

  1. Chen F, Radisky ES, Das P, Batra J, Hata T, Hori T, Baine AM, Gardner L, Yue MY, Bu G, Del Zoppo G, Patel TC, Nguyen JH. TIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure. J Cereb Blood Flow Metab. 2013 Mar 27. [Epub ahead of print] 2313147
    View PubMed
  2. d'Uscio LV, Das P, Santhanam AV, He T, Younkin SG, Katusic ZS. Activation of PPARdelta prevents endothelial dysfunction induced by overexpression of amyloid-beta precursor protein. Cardiovasc Res. 2012 Dec 1; 96(3):504-12. Epub 2012 Aug 10. 2263936
    View PubMed
  3. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012 Feb; 44(2):200-5. Epub 2011 Dec 25. 2213598
    View PubMed
  4. Hanna A, Iremonger K, Das P, Dickson D, Golde T, Janus C. Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis. Alzheimers Res Ther. 2012; 4(3):21. Epub 2012 Jun 14. 2311144
    View PubMed
  5. Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE. Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains. Alzheimers Res Ther. 2012; 4(3):18. Epub 2012 May 23. 2311145
    View PubMed
  6. Rodgers SP, Born HA, Das P, Jankowsky JL. Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult. Mol Neurodegener. 2012; 7:28. Epub 2012 Jun 18. 2281352
    View PubMed
  7. Chakrabarty P, Tianbai L, Herring A, Ceballos-Diaz C, Das P, Golde TE. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition. Mol Neurodegener. 2012; 7:36. Epub 2012 Jul 29. 2285538
    View PubMed
  8. Verbeeck C, Deng Q, Dejesus-Hernandez M, Taylor G, Ceballos-Diaz C, Kocerha J, Golde T, Das P, Rademakers R, Dickson DW, Kukar T. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener. 2012; 7:53. Epub 2012 Oct 10. 2297436
    View PubMed
  9. D'Uscio LV, Das P, Santhanam AVR, He T, Younkin SG, Katusic ZS. Activation of PPAR delta prevents endothelial dysfunction induced by overexpression of amyloid-beta precursor protein. Cardiovasc Res. 2012; 96(3):504-12. 2290155
  10. Das P, Verbeeck C, Minter L, Chakrabarty P, Felsenstein K, Kukar T, Maharvi G, Fauq A, Osborne BA, Golde TE. Transient pharmacologic lowering of Abeta production prior to deposition results in sustained reduction of amyloid plaque pathology. Mol Neurodegener. 2012; 7:39. Epub 2012 Aug 14. 2278557
    View PubMed
  11. Kukar TL, Ladd TB, Robertson P, Pintchovski SA, Moore B, Bann MA, Ren Z, Jansen-West K, Malphrus K, Eggert S, Maruyama H, Cottrell BA, Das P, Basi GS, Koo EH, Golde TE. Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid beta peptide length: support for a sequential model of gamma-secretase intramembrane proteolysis and regulation by the amyloid beta precursor protein (APP) juxtamembrane region. J Biol Chem. 2011 Nov 18; 286(46):39804-12. Epub 2011 Aug 25. 2208953
    View PubMed
  12. Chakrabarty P, Ceballos-Diaz C, Lin WL, Beccard A, Jansen-West K, McFarland NR, Janus C, Dickson D, Das P, Golde TE. Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification. Nat Neurosci. 2011 Jun; 14(6):694-6. Epub 2011 May 15. 2170688
    View PubMed
  13. Wang A, Das P, Switzer RC 3rd, Golde TE, Jankowsky JL. Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci. 2011 Mar 16; 31(11):4124-36. 2152973
    View PubMed
  14. Chakrabarty P, Herring A, Ceballos-Diaz C, Das P, Golde TE. Hippocampal expression of murine TNFalpha results in attenuation of amyloid deposition in vivo. Mol Neurodegener. 2011; 6:16. Epub 2011 Feb 16. 2155411
    View PubMed
  15. Meckler X, Roseman J, Das P, Cheng H, Pei S, Keat M, Kassarjian B, Golde TE, Parent AT, Thinakaran G. Reduced Alzheimer's disease ss-amyloid deposition in transgenic mice expressing S-palmitoylation-deficient APH1aL and nicastrin. J Neurosci. 2010 Dec 1; 30(48):16160-9. 2129847
    View PubMed
  16. Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE, Das P. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol. 2010 May 1; 184(9):5333-43. Epub 2010 Apr 05. 1995632
    View PubMed
  17. Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C, Zubair AC, Dickson D, Golde TE, Das P. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 2010 Feb; 24(2):548-59. Epub 2009 Oct 13. 1969728
    View PubMed
  18. Meckler X, Roseman J, Das P, Cheng H, Pei S, Keat M, Kassarjian B, Golde TE, Parent AT, Thinakaran G. Reduced Alzheimer's disease beta-amyloid deposition in transgenic mice expressing S-palmitoylation-deficient APH1aL and nicastrin. J Neurosci. 2010; 30(48):16160-9. 2136418
  19. McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton-Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, Tansey MG. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis. 2009 Apr; 34(1):163-77. 1952017
    View PubMed
  20. Golde TE, Das P, Levites Y. Quantitative and mechanistic studies of Abeta immunotherapy. CNS Neurol Disord Drug Targets. 2009 Mar; 8(1):31-49. 1931950
    View PubMed
  21. Garcia-Alloza M, Subramanian M, Thyssen D, Borrelli LA, Fauq A, Das P, Golde TE, Hyman BT, Bacskai BJ. Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575. Mol Neurodegener. 2009; 4:19. Epub 2009 May 06. 1970041
    View PubMed
  22. Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, Fauq A, Das P, Golde TE, Osborne BA. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood. 2008 Sep 1; 112(5):1813-21. Epub 2008 Jun 11. 1954927
    View PubMed
  23. Spilman P, Lessard P, Sattavat M, Bush C, Tousseyn T, Huang EJ, Giles K, Golde T, Das P, Fauq A, Prusiner SB, Dearmond SJ. A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci U S A. 2008 Jul 29; 105(30):10595-600. Epub 2008 Jul 22. 1947730
    View PubMed
  24. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A. 2008 Feb 19; 105(7):2681-6. Epub 2008 Feb 12. 1898910
    View PubMed
  25. Fauq AH, Simpson K, Maharvi GM, Golde T, Das P. A multigram chemical synthesis of the gamma-secretase inhibitor LY411575 and its diastereoisomers. Bioorg Med Chem Lett. 2007 Nov 15; 17(22):6392-5. Epub 2007 Aug 30. 1858523
    View PubMed
  26. Li T, Wen H, Brayton C, Das P, Smithson LA, Fauq A, Fan X, Crain BJ, Price DL, Golde TE, Eberhart CG, Wong PC. Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. J Biol Chem. 2007 Nov 2; 282(44):32264-73. Epub 2007 Sep 07. 1848959
    View PubMed
  27. Lawlor PA, Bland RJ, Das P, Price RW, Holloway V, Smithson L, Dicker BL, During MJ, Young D, Golde TE. Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels. Mol Neurodegener. 2007; 2:11 Epub 2007 Jun 9. 1934815
    View PubMed
  28. Levites Y, Smithson LA, Price RW, Dakin RS, Yuan B, Sierks MR, Kim J, McGowan E, Reed DK, Rosenberry TL, Das P, Golde TE. Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models. FASEB J. 2006 Dec; 20(14):2576-8. Epub 2006 Oct 26. 1794590
    View PubMed
  29. Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci. 2006 Nov 15; 26(46):11923-8. 1794486
    View PubMed
  30. Das P, Golde T. Dysfunction of TGF-beta signaling in Alzheimer's disease. J Clin Invest. 2006 Nov; 116(11):2855-7. 1791324
    View PubMed
  31. Maier M, Seabrook TJ, Lazo ND, Jiang L, Das P, Janus C, Lemere CA. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. J Neurosci. 2006 May 3; 26(18):4717-28. 1760876
    View PubMed
  32. Head E, Barrett EG, Murphy MP, Das P, Nistor M, Sarsoza F, Glabe CC, Kayed R, Milton S, Vasilevko V, Milgram NW, Agadjanyan MG, Cribbs DH, Cotman CW. Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta. Vaccine. 2006 Apr 5; 24(15):2824-34. Epub 2006 Jan 19. 1758029
    View PubMed
  33. Levites Y, Das P, Price RW, Rochette M, Kostura, LA, McGowan E, Murphy MP, Golde TE. Anti-Aβ42 and Anti-Aβ40 specific monoclonal antibodies attenuate amyloid deposition in an Alzheimer’s disease mouse model. J Clin Invest. 2006 Jan; 116(1):193-201. 1924441
  34. Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest. 2006 Jan; 116(1):193-201. Epub 2005 Dec 08. 1744221
    View PubMed
  35. Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE. Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy. J Neuroinflammation. 2006; 3:17. Epub 2006 Jul 26. 1824559
    View PubMed
  36. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005 Jul 21; 47(2):191-9. 1729795
    View PubMed
  37. Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, Cho OH, Palaga T, Gottipati S, Telfer JC, Kostura L, Fauq AH, Simpson K, Such KA, Miele L, Golde TE, Miller SD, Osborne BA. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol. 2005 Jul; 6(7):680-8. 1720569
    View PubMed
  38. Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med. 2005 May; 11(5):545-50. Epub 2005 Apr 17. 1716406
    View PubMed
  39. Head E, Moffat K, Das P, Sarsoza E, Poon WW, Landsberg G, Cotman CW, Murphy MP. beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging. 2005 May; 26(5):749-63. 1701634
    View PubMed
  40. Das P, Chapoval S, Howard V, David CS, Golde TE. Immune responses against Abeta1-42 in HLA class II transgenic mice: implications for Abeta1-42 immune-mediated therapies. Neurobiol Aging. 2003 Nov; 24(7):969-76. 1422242
    View PubMed
  41. Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. J Neurosci. 2003 Sep 17; 23(24):8532-8. 1415143
    View PubMed
  42. Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003 Aug; 112(3):440-9. 1407456
    View PubMed
  43. Murphy MP, Das P, Nyborg AC, Rochette MJ, Dodson MW, Loosbrock NM, Souder TM, McLendon C, Merit SL, Piper SC, Jansen KR, Golde TE. Overexpression of nicastrin increases Abeta production. FASEB J. 2003 Jun; 17(9):1138-40. Epub 2003 Apr 08. 1341201
    View PubMed
  44. Das P, Chapoval S, Howard V, David CS, Golde TE. Immune responses against Aβ1-42 in HLA class II transgenic mice: Implications for Aβ1-42 immune-mediated therapies. Neurobiol Aging. 2003; 24:893-1019. 1924426
  45. Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis. 2002 Feb; 9(1):11-23. 1008250
    View PubMed
  46. Wahrle S, Das P, Nyborg AC, McLendon DC, Shoji M, Kawarabayashi T, Younkin LH, Younkin, SG, Golde TE. Cholesterol dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis. 2002; 9(1):11-23. 1924433
  47. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001 Nov 8; 414(6860):212-6. 1934642
    View PubMed
  48. Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging. 2001 Sep-Oct; 22(5):721-7. 1006990
    View PubMed
  49. Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. Reduced effectiveness of Aβ 1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging. 2001; 22:721-7. 1924420
  50. Das P, Drescher KM, Geluk A, Bradley DS, Rodriguez M, David CS. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum Immunol. 2000 Mar; 61(3):279-89. 1013388
    View PubMed
  51. Das P, Abraham R, David C. HLA transgenic mice as models of human autoimmune diseases. Rev Immunogenet. 2000; 2(1):105-14. 1013699
    View PubMed
  52. Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum Immunol. 1999 Jul; 60(7):575-82. 1009960
    View PubMed
  53. Bradley DS, Das P, Griffiths MM, Luthra HS, David CS. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. J Immunol. 1998 Nov 1; 161(9):5046-53. 1019957
    View PubMed
  54. Bradley DS, Das P, Griffiths MM, Luthra HS, David CS. HLA-DQ6/8double transgenic mice develop auricular chondritis following bovine type II collagen immunization. J Immunol. 1998; 161:5046-53. 1924400
  55. Chen S, Das P, Hussein MG, Hari V. Electron microscopic localization of ATPase activity in tobacco cells infected with TEV and TMV. Arch Virol. 1995; 140:173-8. 1953044
  56. Das P, Hari V. Monoclonal antibodies reactive with specific amino acid sequences to the 126K protein of TMV. Arch Virol. 1994; 137:179-83. 1953046
  57. Chen S, Das P, Hari V. In situ localization of ATPase activity in cells infected by Maize Dwarf Mosaic potyvirus. Arch Virol. 1994; 134:433-9. 1953051
  58. Das P, Hari V. Detection of antibodies to HIV p24/25 and gp 120 proteins using SLIDA. Biotechniques. 1993; 14(5):774-80. 1953055
  59. Das P, Hari V. Intracellular distribution of the 126K/183K and capsid proteins in cells infected by some tobamoviruses. J Gen Virol. 1992; 73:3039-43. 1953056
  60. Baunoch DA, Das P, Browning ME, Hari V. A temporal study of the capsid and three non-structural protein of TEV in infected plants. J Gen Virol. 1991; 72:487-92. 1953057
  61. Baunoch DA, Das P, Hari V. Potato virus Y helper component protein is associated with amorphous inclusions. J Gen Virol. 1990; 71:2479-80. 1953058
  62. Hari V, Baunoch DA, Das P. A sensitive Sphere Linked Immuno diagnostic Assay (SLIDA) for detection of antibodies to viruses and other pathogens. Biotechniques. 1990; 9(3):342-50. 1953089
  63. Hari V, Gadh IPS, Baunoch DA, Das P. BMMV; The genome and its translation products. Virus Genes. 1988; 2(3):211-21. 1953090